| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 32.87 |
|
ISIN Demat : INE059A01026 |
Div & Yield% : 0.93 |
EPS(TTM) : 42.61 |
|
Book Value(₹) : 423.36 |
Market Cap(₹Cr) : 113,154.89 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 3,840.92 | 4,256.93 | 4,495.16 | 4,501.66 | 4,254.47 | 4,134.87 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,840.92 | 4,256.93 | 4,495.16 | 4,501.66 | 4,254.47 | 4,134.87 |
| Other Operating Income | 369.06 | 241.15 | 730.56 | 544.51 | 543.42 | 836.01 |
| Other Income | 180.22 | 416.70 | 254.66 | 271.07 | 588.03 | 188.69 |
| Total Income | 4,390.20 | 4,914.78 | 5,480.38 | 5,317.24 | 5,385.92 | 5,159.57 |
| Total Expenditure | 3,642.87 | 4,021.25 | 3,703.09 | 3,421.72 | 3,479.18 | 3,309.05 |
| PBIDT | 747.33 | 893.53 | 1,777.29 | 1,895.52 | 1,906.74 | 1,850.52 |
| Interest | 6.74 | 4.03 | 2.65 | 5.88 | 3.49 | 3.55 |
| PBDT | 740.59 | 889.50 | 1,774.64 | 1,889.64 | 1,903.25 | 1,846.97 |
| Depreciation | 218.11 | 153.33 | 141.30 | 145.69 | 147.70 | 142.62 |
| Tax | 119.77 | 113.87 | 412.22 | 456.04 | 332.71 | 262.96 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 18.07 | 5.42 | 10.59 | -15.22 | -62.56 | 3.24 |
| Reported Profit After Tax | 384.64 | 616.88 | 1,210.53 | 1,303.13 | 1,485.40 | 1,438.15 |
| Extra-ordinary Items | 0.00 | -204.77 | 0.00 | 0.00 | 238.82 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 384.64 | 821.65 | 1,210.53 | 1,303.13 | 1,246.58 | 1,438.15 |
| EPS (Unit Curr.) | 4.76 | 7.64 | 14.99 | 16.13 | 18.39 | 17.81 |
| EPS (Adj) (Unit Curr.) | 4.76 | 7.64 | 14.99 | 16.13 | 18.39 | 17.81 |
| Calculated EPS (Unit Curr.) | 4.76 | 7.64 | 14.99 | 16.13 | 18.39 | 17.81 |
| Calculated EPS (Adj) (Unit Curr.) | 4.76 | 7.64 | 14.99 | 16.13 | 18.39 | 17.81 |
| Calculated EPS (Ann.) (Unit Curr.) | 19.05 | 30.55 | 59.95 | 64.53 | 73.57 | 71.23 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 19.05 | 30.55 | 59.95 | 64.53 | 73.57 | 71.23 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 161.56 | 161.55 | 161.55 | 161.55 | 161.52 | 161.52 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.46 | 20.99 | 39.54 | 42.11 | 44.82 | 44.75 |
| PBDTM(%) | 19.28 | 20.90 | 39.48 | 41.98 | 44.74 | 44.67 |
| PATM(%) | 10.01 | 14.49 | 26.93 | 28.95 | 34.91 | 34.78 |
